Overview
Yuki Takeyasu practices in Hirakata, Japan. Takeyasu is rated as an Advanced expert by MediFind in the treatment of Lung Cancer. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pulmonary Aspergilloma, EGFR Positive Lung Cancer, and Endoscopy.
Their clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 29 articles in the study of Lung Cancer.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerTakeyasu isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Acute Interstitial PneumoniaTakeyasu isExperienced. Learn about Acute Interstitial Pneumonia.
- AgranulocytosisTakeyasu isExperienced. Learn about Agranulocytosis.
- EGFR Positive Lung CancerTakeyasu isExperienced. Learn about EGFR Positive Lung Cancer.
- EndoscopyTakeyasu isExperienced. Learn about Endoscopy.
- Interstitial Lung DiseaseTakeyasu isExperienced. Learn about Interstitial Lung Disease.
- Pulmonary AspergillomaTakeyasu isExperienced. Learn about Pulmonary Aspergilloma.